AnalystsSerge BelangerSerge Belanger's Stock Forecasts
AnalystsSerge Belanger
Analyst Ranking
Top 1%
#42 out of 5165 analysts
Average Return
+21.07%
Win Rate
55%212 out of 388
Risk vs Reward
Poor
Good
Serge Belanger's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Trevi Therapeutics IncTRVI | +426.92% | $2.60 | $13.70 | 2024-12-03 - 2025-12-03 | Buy |
Esperion Therapeutics IncESPR | +327.10% | $0.87 | $3.72 | 2025-05-06 - 2026-01-06 | Buy |
Esperion Therapeutics IncESPR | +304.35% | $0.92 | $3.72 | 2025-04-24 - 2026-01-06 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Serge Belanger Analyst Color
Get additional color on Serge Belanger's coverage of popular stocks
Serge Belanger's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kalvista Pharmaceuticals IncKALV | 21 | Buy | $32.00 | +103.17% | Maintains | a day ago |
Viridian Therapeutics IncVRDN | 19 | Buy | $42.00 | +36.72% | Maintains | 15 days ago |
Cytokinetics IncCYTK | 26 | Buy | $84.00 | +30.03% | Maintains | 16 days ago |
Ocular Therapeutix IncOCUL | 6 | Buy | $20.00 | +77.78% | Reiterates | a month ago |
Cormedix IncCRMD | 19 | Buy | $16.00 | +42.10% | Maintains | 2 months ago |
Oculis Holding AgOCS | 2 | Buy | $36.00 | +72.25% | Reiterates | 2 months ago |
Amphastar Pharmaceuticals IncAMPH | 3 | Buy | $34.00 | +23.10% | Maintains | 2 months ago |
Newamsterdam Pharma Co NvNAMS | 10 | Buy | $46.00 | +35.21% | Maintains | 2 months ago |
Biocryst Pharmaceuticals IncBCRX | 18 | Buy | $18.00 | +137.47% | Maintains | 2 months ago |
Liquidia CorpLQDA | 33 | Buy | $52.00 | +69.27% | Maintains | 2 months ago |
Xenon Pharmaceuticals IncXENE | 13 | Buy | $55.00 | +34.15% | Reiterates | 2 months ago |
Arcutis Biotherapeutics IncARQT | 23 | Buy | $30.00 | +2.67% | Maintains | 2 months ago |
Collegium Pharmaceutical IncCOLL | 22 | Buy | $46.00 | -0.45% | Reiterates | 2 months ago |
Moonlake ImmunotherapeuticsMLTX | 13 | Buy | $20.00 | +79.05% | Maintains | 3 months ago |
Heron Therapeutics IncHRTX | 21 | Buy | $3.00 | +145.90% | Maintains | 5 months ago |
Trevi Therapeutics IncTRVI | 20 | Buy | $22.00 | +100.36% | Maintains | 5 months ago |
Evolus IncEOLS | 16 | Hold | $22.00 | +272.25% | Downgrades | 5 months ago |
Clearside Biomedical IncCLSDQ | 16 | Hold | $45.00 | +10,875.61% | Downgrades | 6 months ago |
Pacira Biosciences IncPCRX | 27 | Buy | $30.00 | +18.53% | Maintains | 8 months ago |
Esperion Therapeutics IncESPR | 20 | Buy | $4.00 | +7.53% | Maintains | 8 months ago |
Verrica Pharmaceuticals IncVRCA | 14 | Hold | $120.00 | N/A | Downgrades | a year ago |
Revance Therapeutics IncRVNC | 16 | Buy | $12.00 | N/A | Reiterates | a year ago |
Dice Therapeutics IncDICE | 1 | Buy | $56.00 | N/A | Reiterates | 3 years ago |
Tricida IncTCDAQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Phasebio Pharmaceuticals IncPHASQ | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aerie Pharmaceuticals IncAERI | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Akebia Therapeutics IncAKBA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Zogenix IncZGNX | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Flexion Therapeutics IncFLXN1 | 1 | Buy | $18.00 | N/A | Maintains | 4 years ago |
Calcimedica IncCALC | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Gw Pharmaceuticals PLCGWPH | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.